Lv11
36 积分 2022-10-12 加入
Recent advancements at ASCO 2024 in PD-L1 and PD-1 bispecific antibodies
5小时前
待确认
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients
2天前
已完结
Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma
3天前
已完结
“Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022
4天前
已完结
Total Neoadjuvant Therapy for Pancreatic Cancer—What Is Totality?
4天前
已完结
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
1个月前
已完结
Cadonilimab: First Approval
1个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
1个月前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
1个月前
已完结
Endometrial cancer
3个月前
已完结
皖公网安备34019202002308
